Alembic Pharmaceuticals has acquired a US based generic drug developer West Caldwell, New Jersey. With this acquisition Alembic will now have a total of 69 abbreviated new drug application (ANDA) approvals (61 final and eight tentative) from United States Food & Drug Administration (US FDA). Further, the acquisition also brings a competent Dr Satish Patel, an experienced leader from the US generic pharmaceuticals industry to the Alembic group.
Company Profile : Alembic Pharmaceuticals Ltd
Leave a Reply